| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/27/1993 | US5206351 Process for the preparation of 2-amino (2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl)adenine |
| 04/27/1993 | US5206270 Method of inhibiting melanoma cells |
| 04/27/1993 | US5206269 Highly concentrated amino acid solution |
| 04/27/1993 | US5206268 Medicaments |
| 04/27/1993 | US5206267 Suspension of butyl aminobenzoate; sterility; stability; nontoxic; polyethylene glycol suspending agent; wetting agent; for subcutaneous injection |
| 04/27/1993 | US5206265 Iron citrate complex, process for its production, and its pharmaceutical |
| 04/27/1993 | US5206264 Reduces damage caused by hypoxic or ischemic events |
| 04/27/1993 | US5206262 Soluble salts of ibuprofen and naproxen with N-(2-hydroxyethyl) pyrrolidine and pharmaceutic compositions containing said salts |
| 04/27/1993 | US5206261 Oxindole derivative |
| 04/27/1993 | US5206258 Use of heteroaryl-3-oxo-propanenitrile derivatives in treating clinical wherein myelopoiesis suppression occurs |
| 04/27/1993 | US5206256 Aromatase inhibitors |
| 04/27/1993 | US5206255 Heterocyclic compound |
| 04/27/1993 | US5206254 β-carbonyl-carboxyamides of 1,3-thiazolidines |
| 04/27/1993 | US5206253 Disphosphonic acid derivatives, processes for their production and pharmaceutical preparations containing these compounds |
| 04/27/1993 | US5206251 Viricide |
| 04/27/1993 | US5206250 Bis-naphthalimides containing amide and thioamide linkers as anticancer agents |
| 04/27/1993 | US5206249 Bis-naphthalimides containing amino-acid derived linkers as anticancer agents |
| 04/27/1993 | US5206248 Method for reducing emotional lability |
| 04/27/1993 | US5206247 Spiro(4.5.)decane compounds |
| 04/27/1993 | US5206243 Control of fungal infections in aquaculture |
| 04/27/1993 | US5206241 Labdanes and process for their preparation |
| 04/27/1993 | US5206239 Pyrroloazepine derivatives |
| 04/27/1993 | US5206238 Analgesics and anesthetics |
| 04/27/1993 | US5206237 Benzodiazepine analogs |
| 04/27/1993 | US5206235 Animal growth regulators; stimulants |
| 04/27/1993 | US5206234 Benzolactam analogs as antagonists of cck |
| 04/27/1993 | US5206230 Antitumor agents |
| 04/27/1993 | US5206229 Inhibit cell proliferation, antiinflammatory, treating imbalance of immune system |
| 04/27/1993 | US5206226 Method of treatment of Parkinsons's disease using phytic acid |
| 04/27/1993 | US5206224 Lowering level of male hormone by administering etherified cyclodextrin |
| 04/27/1993 | US5206222 Coadministering adenosine or an analog and lidocaine |
| 04/27/1993 | US5206220 Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition |
| 04/27/1993 | US5206218 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa) |
| 04/27/1993 | US5206029 Separated enantiomorphs of flurbiprofen recombined in varying ratios, release agent |
| 04/27/1993 | US5206018 Use of rapamycin in treatment of tumors |
| 04/27/1993 | US5206008 Using androstene(diol or triol) |
| 04/27/1993 | CA1316933C Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| 04/27/1993 | CA1316932C Methods and compositions for inhibiting lipoxygenase |
| 04/27/1993 | CA1316929C Method of inhibiting virus |
| 04/27/1993 | CA1316928C Alpha-heterocycle substituted tolunitriles |
| 04/27/1993 | CA1316927C Antihypercholesterolemic beta-lactones |
| 04/27/1993 | CA1316926C Nicotinoylpiperazine derivatives, method of preparation and use in therapy |
| 04/27/1993 | CA1316924C Etheric derivative of 4/3h/-quinazolinone and a process for the preparation thereof |
| 04/27/1993 | CA1316922C Carboxylic acid derivatives, processes for the preparation thereof, the use thereof and pharmaceutical compositions containing them |
| 04/27/1993 | CA1316921C Cyclohexane derivative |
| 04/27/1993 | CA1316916C Hydroxide mediated fk-506 rearrangement product |
| 04/27/1993 | CA1316915C Macrolide antibiotics and their preparation |
| 04/27/1993 | CA1316914C Process for the preparation of methylene derivatives of androsta-1,4-diene-3,17-dione |
| 04/27/1993 | CA1316832C Treatment of human viral infection by dsrna combined with viral inhibitors |
| 04/27/1993 | CA1316831C Anti-plasmin factor depressant |
| 04/27/1993 | CA1316830C Agent for treating or preventing thrombocytopenia |
| 04/27/1993 | CA1316829C Therapeutic composition containing sucrose fatty acid ester |
| 04/27/1993 | CA1316828C Compounds having anti-metastatic and/or anti-inflammatory activity |
| 04/27/1993 | CA1316827C Prevention and treatment of the deleterious effects of exposing skin to the sun, and compositions therefor |
| 04/27/1993 | CA1316820C Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use |
| 04/27/1993 | CA1316649C Moulding contact lenses |
| 04/26/1993 | WO1993007876A1 Remedy for hepatic disease |
| 04/26/1993 | CA2081303A1 Process for the preparation of substituted indoles |
| 04/26/1993 | CA2081262A1 Acetylene compounds |
| 04/26/1993 | CA2081007A1 Cytotoxic bicyclo¬7.3.1|tridec-4-ene-2, 6-diyne compounds and process for the preparation thereof |
| 04/25/1993 | WO1993007880A1 Anti-microbial mafenide-phosphanilate compound, pharmaceutical compositions and method of use therefor |
| 04/25/1993 | CA2098996A1 Anti-microbialmafenide-phosphanilate compound, pharmaceutical compositions and method of use therefor |
| 04/25/1993 | CA2081133A1 Pharmaceutical compounds |
| 04/25/1993 | CA2081062A1 Treatment of anxiety in benzodiazepine-withdrawn patients |
| 04/24/1993 | CA2081186A1 Nitrogen-containing tetracyclic compounds having anti-allergic and anti-asthmatic activities, their preparation and use |
| 04/24/1993 | CA2081173A1 N-phenyl-2-cyano-3-hydroxycrotonamide derivatives and their use as pharmaceuticals having an immunomodulatory property |
| 04/24/1993 | CA2081147A1 Naphthamide derivatives, process for preparing them and their application in the therapeutic field |
| 04/24/1993 | CA2081134A1 Hiv protease inhibitors |
| 04/24/1993 | CA2081061A1 Improved lyophilized ifosfamide compositions |
| 04/24/1993 | CA2081049A1 Thiadiazinones |
| 04/23/1993 | WO1993007877A1 Method for memory enhancement and quality of life improvement |
| 04/23/1993 | CA2098399A1 Method for memory enhancement and quality of life improvement |
| 04/23/1993 | CA2080867A1 Use of substituted pyrrolidines, some of which are known, as medicaments, new active substances and processes for their preparation |
| 04/23/1993 | CA2080864A1 Aryl-quinolyl-substituted 1,4-dihydropyridine-dicarboxylic acid derivatives, processes for their preparation and their use in drugs |
| 04/23/1993 | CA2080863A1 Use of substituted tetrahydrothiophenes, some of which are known, as medicaments, new active substances and processes for their preparation |
| 04/23/1993 | CA2079539A1 Organotin compounds having anti-tumour activity and anti-tumour compositions |
| 04/23/1993 | CA2053962A1 Benzopyran derivatives, process for their preparation and use thereof and preparations containing the compounds |
| 04/22/1993 | CA2080950A1 Therapeutic agent |
| 04/22/1993 | CA2080949A1 Therapeutic agents |
| 04/22/1993 | CA2080671A1 Benzothiazepine derivatives |
| 04/21/1993 | EP0538231A1 Fungicides for the control of take-all disease of plants |
| 04/21/1993 | EP0538222A1 3-(N-Isopropyl-N-n-propylamino)-5-(N-isopropyl)carbamoylchroman as a selective 5-hydroxytryptamine receptor stimulant |
| 04/21/1993 | EP0538194A1 Bicyclic nucleosides, oligonucleotides, their method of preparation and intermediates therein |
| 04/21/1993 | EP0538193A2 Condensed cycloaliphatir-amidino-hydrazon salts as S-adenosylmethionin decarboxylase inhibitors |
| 04/21/1993 | EP0538192A1 New 17-beta-substituted aza-androstanderivatives |
| 04/21/1993 | EP0538134A2 Mono-fluorinated derivatives of N-propargyl-1-aminoindan and their use as inhibitors of monoamine oxidase |
| 04/21/1993 | EP0538101A1 Process for the preparation of benzo(b)naphthyridines |
| 04/21/1993 | EP0538100A1 New fluoro-quinolin-3-carboxylic acid derivatives and their preparation |
| 04/21/1993 | EP0538099A1 3-ureido-benzodiazepinones useful as CCK or gastrin antagonists |
| 04/21/1993 | EP0538080A1 4-Aminomethylpiperidine derivatives, process for their preparation and their use in therapy |
| 04/21/1993 | EP0538018A1 (N-pyridiniumphenyl)-carbapenems |
| 04/21/1993 | EP0538017A1 2-(N-Imidazoliumphenyl)-carbapenems |
| 04/21/1993 | EP0538016A1 MRSA active 2-phenyl-carbapenems |
| 04/21/1993 | EP0538011A1 Lipophilic oligosaccharide antibiotic salt compositions |
| 04/21/1993 | EP0538001A1 MRSA active 2-halophenyl carbapenems |
| 04/21/1993 | EP0538000A1 Indole and indazole carbamates as leukotriene antagonists |
| 04/21/1993 | EP0537998A1 Controlled release drug delivery device comprising a polymer matrix and a plasticizer |
| 04/21/1993 | EP0537996A1 Avermectin compounds with a 6,5-spiroketal ring system and a 23-acyl substituent |
| 04/21/1993 | EP0537993A1 Nicotinic activity of a series of arecolones and isoarecolones |
| 04/21/1993 | EP0537980A1 Cyclohexaneacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation |